SCHEMBL6987573

SCHEMBL6987573

NCC(=O)Oc1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
PARP1 P09874 1/20 0.43
NPSR1 Q6W5P4 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ACHE P22303 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MAOB P27338 2/20 0.41
NR4A2 P43354 1/20 0.41
PARP10 Q53GL7 1/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15763906 0.85 MEN1 (0.52) MEN1KMT2AALDH1A1HPGDESR1
SCHEMBL27821595 0.84 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDESR1
SCHEMBL22265088 0.83 MEN1 (0.48) MEN1KMT2AALDH1A1HPGDESR1
SCHEMBL29852392 0.82 ACHE (0.61) MEN1KMT2AALDH1A1HPGDESR1
SCHEMBL1021094 0.82 ACHE (0.61) MEN1KMT2AALDH1A1HPGDESR1
Hydrochloric Acid SCHEMBL27841047 0.81 TAAR1 (0.53) MEN1KMT2AALDH1A1HPGDESR2
SCHEMBL27555828 0.81 CYP4F2 (0.44) MEN1KMT2AALDH1A1HPGDCES2
SCHEMBL20335031 0.80 LMNA (0.65) MEN1KMT2AALDH1A1PPARGACHE
SCHEMBL4633863 0.80 CYP3A4 (0.59) MEN1KMT2AALDH1A1ESR1ESR2
SCHEMBL27771513 0.80 CYP3A4 (0.47) MEN1KMT2AALDH1A1ACHEMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105283439-B The dibenzoylhydrazine of boracic 英特瑞克斯顿股份有限公司 2018-02-02 CN disclosed
EP-3194359-A1 BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS Intrexon Corporation (US) 2017-07-26 EP disclosed
WO-2016044390-A1 BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS INTREXON CORPORATION (US) 2016-03-24 WO disclosed
CN-105283439-A BORON-CONTAINING DIACYLHYDRAZINES INTREXON CORP 2016-01-27 CN disclosed
CN-102056927-B Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors IRM LLC 2014-06-25 CN disclosed
CN-102056927-A Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors IRM LLC 2011-05-11 CN disclosed
CN-101104862-B Method for synthesizing D-arylglycine by using heterogeneous enzyme to catalytically hydrolyzing 5-arylhydantoin UNIV HEBEI SCIENCE & TECH 2010-05-19 CN disclosed
CN-101627007-A Aminoamides as orexin antagonists HOFFMANN LA ROCHE 2010-01-13 CN disclosed
CN-100398555-C Protease inhibitors for coronaviruses and SARS-COV and the use thereof CYTOVIA INC (US) 2008-07-02 CN disclosed
CN-101104862-A Method for synthesizing D-arylglycine by using heterogeneous enzyme to catalytically hydrolyzing 5-arylhydantoin UNIV HEBEI SCIENCE & TECH (CN) 2008-01-16 CN disclosed
CN-1984909-A Thiazolinone unsubstituted quinolines HOFFMANN LA ROCHE (CH) 2007-06-20 CN disclosed
CN-1784239-A Protease inhibitors of coronavirus and SARS-COV and use thereof CYTOVIA INC (US) 2006-06-07 CN disclosed
EP-1289972-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-03-12 EP disclosed
EP-1289954-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-03-12 EP disclosed
WO-2001096323-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2001-12-20 WO disclosed
WO-2001096303-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2001-12-20 WO disclosed
CN-1297354-A Dipeptide caspase inhibitors and use thereof CYTOVIA INC (US) 2001-05-30 CN disclosed